These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29619858)

  • 21. Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema.
    Shimizu N; Oshitari T; Tatsumi T; Takatsuna Y; Arai M; Sato E; Baba T; Yamamoto S
    Biomed Res Int; 2017; 2017():1747108. PubMed ID: 28758110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between anterior chamber flare changes and diabetic macular edema after intravitreal injection of ranibizumab and aflibercept.
    Shiraya T; Kure K; Araki F; Kato S; Kaiya T
    Jpn J Ophthalmol; 2020 May; 64(3):250-256. PubMed ID: 32108920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of leaking perifoveal microaneurysms on resolution of diabetic macular edema treated by combination therapy using anti-vascular endothelial growth factor and short pulse focal/grid laser photocoagulation.
    Hirano T; Toriyama Y; Iesato Y; Imai A; Hirabayashi K; Nagaoka T; Takamura Y; Sugimoto M; Murata T
    Jpn J Ophthalmol; 2017 Jan; 61(1):51-60. PubMed ID: 27730425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optical coherence tomographic patterns in diabetic macula edema can predict the effects of intravitreal bevacizumab injection as primary treatment.
    Wu PC; Lai CH; Chen CL; Kuo CN
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):59-64. PubMed ID: 21992557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal Ranibizumab Alone or in Combination with Calcium Dobesilate for the Treatment of Diabetic Macular Edema in Nonproliferative Diabetic Retinopathy Patients: 12-Month Outcomes of a Retrospective Study.
    Wang D; Wang H; Wu S; Yang X; Xu J
    Int J Clin Pract; 2022; 2022():6725225. PubMed ID: 36340967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Symmetry in early response to intravitreal ranibizumab in bilateral diabetic macular oedema.
    Guillard M; Dupas B; El Sanharawi M; Erginay A; Tadayoni R; Massin P
    Acta Ophthalmol; 2016 Aug; 94(5):e356-60. PubMed ID: 26564668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetic macular edema with neuroretinal detachment: OCT and OCT-angiography biomarkers of treatment response to anti-VEGF and steroids.
    Vujosevic S; Toma C; Villani E; Muraca A; Torti E; Florimbi G; Leporati F; Brambilla M; Nucci P; De Cilla' S
    Acta Diabetol; 2020 Mar; 57(3):287-296. PubMed ID: 31541333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of ranibizumab 0.5 mg in Chinese patients with visual impairment due to diabetic macular edema: results from the 12-month REFINE study.
    Li X; Dai H; Li X; Han M; Li J; Suhner A; Lin R; Wolf S;
    Graefes Arch Clin Exp Ophthalmol; 2019 Mar; 257(3):529-541. PubMed ID: 30645696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of different anti-vascular endothelial growth factor agents, and dexamethasone implant therapy in patients with serous retinal detachment caused by Irvine-Gass syndrome.
    Karasu B; Kesim E; Celebi ARC
    Eur J Ophthalmol; 2024 Mar; 34(2):510-523. PubMed ID: 37408434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of intravitreal injection of ranibizumab on choroidal structure and blood flow in eyes with diabetic macular edema.
    Okamoto M; Yamashita M; Ogata N
    Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):885-892. PubMed ID: 29492689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between the patterns of diabetic macular edema and photoreceptors' response after intravitreal ranibizumab treatment: a spectral-domain optical coherence tomography study.
    Chatziralli I; Theodossiadis G; Dimitriou E; Kazantzis D; Theodossiadis P
    Int Ophthalmol; 2020 Oct; 40(10):2441-2448. PubMed ID: 32424527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between characteristics of foveal cystoid spaces and short-term responsiveness to ranibizumab for diabetic macular edema.
    Murakami T; Suzuma K; Uji A; Yoshitake S; Dodo Y; Fujimoto M; Yoshitake T; Miwa Y; Yoshimura N
    Jpn J Ophthalmol; 2018 May; 62(3):292-301. PubMed ID: 29460019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome and Predictors for 2-Year Visual Acuity in Eyes with Diabetic Macular Edema Treated with Ranibizumab.
    Eski Yucel O; Birinci H; Sullu Y
    J Ocul Pharmacol Ther; 2019 May; 35(4):229-234. PubMed ID: 30896316
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognostic significance of foveal capillary drop-out and previous panretinal photocoagulation for diabetic macular oedema treated with ranibizumab.
    Ebneter A; Wolf S; Zinkernagel MS
    Br J Ophthalmol; 2016 Mar; 100(3):365-70. PubMed ID: 26187951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study.
    Prünte C; Fajnkuchen F; Mahmood S; Ricci F; Hatz K; Studnička J; Bezlyak V; Parikh S; Stubbings WJ; Wenzel A; Figueira J;
    Br J Ophthalmol; 2016 Jun; 100(6):787-95. PubMed ID: 26453639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural and functional assessment after intravitreal injection of ranibizumab in diabetic macular edema.
    Fu Y; Wang P; Meng X; Du Z; Wang D
    Doc Ophthalmol; 2017 Dec; 135(3):165-173. PubMed ID: 28756595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aqueous cytokine and growth factor levels indicate response to ranibizumab for diabetic macular oedema.
    Shimura M; Yasuda K; Motohashi R; Kotake O; Noma H
    Br J Ophthalmol; 2017 Nov; 101(11):1518-1523. PubMed ID: 28270488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment outcomes and predicting factors for diabetic macular edema treated with ranibizumab - One-year real-life results in Taiwan.
    Lai TT; Yang CM; Yang CH; Ho TC; Hsieh YT
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):194-202. PubMed ID: 29609918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ranibizumab for the Treatment of Diabetic Macular Oedema in the Real-World Clinical Setting in Portugal: A Multicentre Study.
    Farinha C; Martins A; Neves A; Soares R; Ruão M; Ornelas M; Neves P; Gomes Rodrigues F; Coelho C; Silva R
    Ophthalmologica; 2019; 241(1):1-8. PubMed ID: 29886497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optical coherence tomography classifications of diabetic macular edema and response to aflibercept: One-year follow-up outcomes in a Chinese population.
    Gu Z; Xi T; Zhang C; Yang G
    Medicine (Baltimore); 2023 Jan; 102(4):e32815. PubMed ID: 36705371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.